APA

Graff G. R., Maguiness K., McNamara J., Morton R., Boyd D., Beckmann K. & Bennett D. (20100514). Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. : Clinical therapeutics.

Chicago

Graff Gavin R, Maguiness Karen, McNamara John, Morton Ronald, Boyd David, Beckmann Katrin and Bennett Djenane. 20100514. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. : Clinical therapeutics.

Harvard

Graff G. R., Maguiness K., McNamara J., Morton R., Boyd D., Beckmann K. and Bennett D. (20100514). Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. : Clinical therapeutics.

MLA

Graff Gavin R, Maguiness Karen, McNamara John, Morton Ronald, Boyd David, Beckmann Katrin and Bennett Djenane. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. : Clinical therapeutics. 20100514.